Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.

about

Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles.

P2860

Q38423724-5BD80712-D887-4C35-AD97-193E3C25D932

P2860

Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.

Item

http://www.wikidata.org/entity/Q42249041

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Microbially synthesized modula ...... riable antigenic determinants.

@en

Microbially synthesized modula ...... riable antigenic determinants.

@nl

type

Item

label

Microbially synthesized modula ...... riable antigenic determinants.

@en

Microbially synthesized modula ...... riable antigenic determinants.

@nl

prefLabel

Microbially synthesized modula ...... riable antigenic determinants.

@en

Microbially synthesized modula ...... riable antigenic determinants.

@nl

P1476

Microbially synthesized modula ...... ariable antigenic determinants

@en

P2093

Anton P J Middelberg

http://www.w3.org/2001/XMLSchema#string

Fiona K Hughes

http://www.w3.org/2001/XMLSchema#string

Michael R Batzloff

http://www.w3.org/2001/XMLSchema#string

Nani Wibowo

http://www.w3.org/2001/XMLSchema#string

Yang Wu

http://www.w3.org/2001/XMLSchema#string

Yap P Chuan

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection.

The global burden of group A streptococcal diseases.

Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci

The streptococcal M protein: a highly versatile molecule.

Virus-like particles as immunogens.

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

Towards the preparative and large-scale precision manufacture of virus-like particles.

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

New understanding of the group A Streptococcus pathogenesis cycle.

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.

P304

1062-1070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIT.25172

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Linda Lua

Natalie K Connors

P577

2013-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24338691

http://www.w3.org/2001/XMLSchema#string

Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.

about

P2860

P2860

Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698